Stimulation method for the sphenopalatine ganglia, sphenopalatine nerve, or vidian nerve for treatment of medical conditions

• US 8,394,075 B2
• Filed: 11/30/2011
• Issued: 03/12/2013
• Est. Priority Date: 06/16/2000
• Status: Expired due to Term

• Current Assignee: Mehdi M. Ansarinia
• Original Assignee: Mehdi M. Ansarinia
• Inventors: Ansarinia, Mehdi M.
• Primary Examiner(s): STIGELL, THEODORE J
• Application Number:
  US13/307,520
• Publication Number:
  US 20120071811A1
• Time in Patent Office: 468 Days
• Field of Search: 604 20- 21, 604500-501, 604/502, 604/506, 604/508, 604/512, 607 1- 3, 607 40- 49
• US Class Current: 604/500
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/3605 Implantable neurostimulators for stimulating central or peripheral nerve system
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36075 Headache or migraine

Abstract

A method is provided for suppressing or preventing pain in a patient. One step of the method includes positioning first and second electrodes, without penetrating the cranium, on or proximate to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves on both sides of the patient'"'"'s face. At least one of a medication solution, an analgesic, or an electrical signal is then applied to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves through the first and second electrodes. Pain signal generation in, or transmission through, the at least one of the sphenopalatine ganglia, sphenopalatine nerves, or vidian nerves is disrupted on both sides of the patient'"'"'s face.

Claims

1. A method for suppressing or preventing pain in a patient, the method comprising the steps of:

advancing a first electrode, without penetrating the cranium, on or proximate to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves on one side of the patient'"'"'s face;

advancing a second electrode, without penetrating the cranium, on or proximate to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves on the other side of the patient'"'"'s face;

applying at least one of a medication solution, an analgesic, or an electrical signal to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves through the first electrode;

applying at least one of a medication solution, an analgesic, or an electrical signal to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or the vidian nerves through the second electrode;

disrupting pain signal generation in, or transmission through, the at least one of the sphenopalatine ganglia, sphenopalatine nerves, or vidian nerves on the one side of the patient'"'"'s face; and

disrupting pain signal generation in, or transmission through, the at least one of the sphenopalatine ganglia, sphenopalatine nerves, or vidian nerves on the other side of the patient'"'"'s face;

wherein each of the first and second electrodes is advanced without penetrating the nasal cavity or the palate.

2. The method of claim 1 further comprising the step of:

applying an electrical signal through each of the first and second electrodes.

3. The method of claim 1 further comprising the steps of:

applying an electrical signal through the first electrode; and

applying a medication solution or analgesic through the second electrode.

4. The method of claim 1 further comprising the step of:

applying a medication solution or analgesic through each of the first and second electrodes.

5. The method of claim 1 further comprising the step of:

adjusting at least one of the amount of the medication solution or the analgesic applied, the rate of applying the medication solution or the analgesic, and the time period of applying the medication solution or the analgesic.

6. The method of claim 5, the amount of the medication solution or the analgesic applied, the rate of applying the medication solution or the analgesic, and the time period of applying the medication solution or the analgesic being controllable by a reservoir or a medication pump.

7. The method of claim 1, wherein at least one of the first and second electrodes is remotely controlled using a remote control device which is accessible from outside the body of the patient.

8. The method of claim 1, wherein at least one of the first and second electrodes is powered by a power source surgically implanted within the patient.